253 related articles for article (PubMed ID: 9855642)
1. Agonist action of adenosine triphosphates at the human P2Y1 receptor.
Palmer RK; Boyer JL; Schachter JB; Nicholas RA; Harden TK
Mol Pharmacol; 1998 Dec; 54(6):1118-23. PubMed ID: 9855642
[TBL] [Abstract][Full Text] [Related]
2. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
[TBL] [Abstract][Full Text] [Related]
3. Agonist binding and Gq-stimulating activities of the purified human P2Y1 receptor.
Waldo GL; Harden TK
Mol Pharmacol; 2004 Feb; 65(2):426-36. PubMed ID: 14742685
[TBL] [Abstract][Full Text] [Related]
4. Identification of competitive antagonists of the P2Y1 receptor.
Boyer JL; Romero-Avila T; Schachter JB; Harden TK
Mol Pharmacol; 1996 Nov; 50(5):1323-9. PubMed ID: 8913364
[TBL] [Abstract][Full Text] [Related]
5. Separate P2T and P2U purinergic receptors with similar second messenger signaling pathways in UMR-106 osteoblasts.
Sistare FD; Rosenzweig BA; Contrera JG; Jordan B
J Pharmacol Exp Ther; 1994 Jun; 269(3):1049-61. PubMed ID: 8014849
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the influence of nucleotidases on the apparent activity of exogenous ATP and ADP at P2Y1 receptors.
Vigne P; Breittmayer JP; Frelin C
Br J Pharmacol; 1998 Oct; 125(4):675-80. PubMed ID: 9831901
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a Ca2+ response to both UTP and ATP at human P2Y11 receptors: evidence for agonist-specific signaling.
White PJ; Webb TE; Boarder MR
Mol Pharmacol; 2003 Jun; 63(6):1356-63. PubMed ID: 12761346
[TBL] [Abstract][Full Text] [Related]
8. Osteoblast responses to nucleotides increase during differentiation.
Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
[TBL] [Abstract][Full Text] [Related]
9. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
10. Cytoprotection against oxidative stress-induced damage of astrocytes by extracellular ATP via P2Y1 receptors.
Shinozaki Y; Koizumi S; Ishida S; Sawada J; Ohno Y; Inoue K
Glia; 2005 Jan; 49(2):288-300. PubMed ID: 15494980
[TBL] [Abstract][Full Text] [Related]
11. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of the human P2Y13 receptor.
Marteau F; Le Poul E; Communi D; Communi D; Labouret C; Savi P; Boeynaems JM; Gonzalez NS
Mol Pharmacol; 2003 Jul; 64(1):104-12. PubMed ID: 12815166
[TBL] [Abstract][Full Text] [Related]
13. ATP derivatives are antagonists of the P2Y1 receptor: similarities to the platelet ADP receptor.
Hechler B; Vigne P; Léon C; Breittmayer JP; Gachet C; Frelin C
Mol Pharmacol; 1998 Apr; 53(4):727-33. PubMed ID: 9547364
[TBL] [Abstract][Full Text] [Related]
14. ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor.
Kennedy C; Qi AD; Herold CL; Harden TK; Nicholas RA
Mol Pharmacol; 2000 May; 57(5):926-31. PubMed ID: 10779375
[TBL] [Abstract][Full Text] [Related]
15. Selective stimulation of catecholamine release from bovine adrenal chromaffin cells by an ionotropic purinergic receptor sensitive to 2-methylthio ATP.
Tomé AR; Castro E; Santos RM; Rosário LM
BMC Neurosci; 2007 Jun; 8():41. PubMed ID: 17584495
[TBL] [Abstract][Full Text] [Related]
16. Expression of a cloned P2Y purinergic receptor that couples to phospholipase C.
Filtz TM; Li Q; Boyer JL; Nicholas RA; Harden TK
Mol Pharmacol; 1994 Jul; 46(1):8-14. PubMed ID: 8058061
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of a novel cyclic AMP-linked P2 receptor on undifferentiated HL-60 leukemia cells.
Conigrave AD; Lee JY; van der Weyden L; Jiang L; Ward P; Tasevski V; Luttrell BM; Morris MB
Br J Pharmacol; 1998 Aug; 124(7):1580-5. PubMed ID: 9723974
[TBL] [Abstract][Full Text] [Related]
18. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
[TBL] [Abstract][Full Text] [Related]
19. Opposite diastereoselective activation of P2Y1 and P2Y11 nucleotide receptors by adenosine 5'-O-(alpha-boranotriphosphate) analogues.
Ecke D; Tulapurkar ME; Nahum V; Fischer B; Reiser G
Br J Pharmacol; 2006 Oct; 149(4):416-23. PubMed ID: 16953187
[TBL] [Abstract][Full Text] [Related]
20. Dual effect of nucleotides on P2Y receptors.
Sak K; Barnard EA; Järv J
IUBMB Life; 2000 Aug; 50(2):99-103. PubMed ID: 11185965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
